|
|
| | 1,3-DiMethyl-6-aMino-1H-indazole Basic information |
| Product Name: | 1,3-DiMethyl-6-aMino-1H-indazole | | Synonyms: | 1,3-DiMethyl-6-aMino-1H-i...;1,3-DiMethyl-6-aMino-1H-indazole;1,3-dimethyl-1H-indazol-6-amine;1H-Indazol-6-amine, 1,3-dimethyl-;1,3-Dimethylindazol-6-amine;Pazopanib Impurity 17;1,3-Dimethyl-1H-indazol-6-ylamine | | CAS: | 221681-92-1 | | MF: | C9H11N3 | | MW: | 161.2 | | EINECS: | | | Product Categories: | | | Mol File: | 221681-92-1.mol |  |
| | 1,3-DiMethyl-6-aMino-1H-indazole Chemical Properties |
| Boiling point | 335.4±22.0 °C(Predicted) | | density | 1.23±0.1 g/cm3(Predicted) | | storage temp. | Keep in dark place,Inert atmosphere,Room temperature | | pka | 3.93±0.50(Predicted) |
| | 1,3-DiMethyl-6-aMino-1H-indazole Usage And Synthesis |
| Uses | 1,3-dimethyl-1H-indazol-6-amine is an impurity in the synthesis of Pazopanib (P210925) which is an oral angiogenesis inhibitor targeting VEGFR and PDGFR. It is used as a reagent in the preparation of glycinamide derivatives which are useful in production of drugs for preventing and treating diseases caused by S-adenosyl homocysteine hydrolase. |
| | 1,3-DiMethyl-6-aMino-1H-indazole Preparation Products And Raw materials |
|